[ad_1]
"We conclude that increases in insulin expenditures result mainly from rising insulin prices and, to a lesser extent, from the shift to the use of more expensive products," the report authors wrote. , Jean Fuglesten Biniek and William Johnson. The authors badyzed the claims data of 3 major insurers.
The report's authors noted that people with type 1 diabetes spent $ 5,705 on insulin in 2016, up from $ 2,864 in 2012.
The report comes just a week after Elijah E. Cummings, representative of Maryland, chairman of the Monitoring and Reform Committee, announced that he had sent letters to 12 pharmaceutical companies asking for information and detailed documentation of their pricing practices. The committee will hold several hearings in the coming weeks to hear experts, as well as patients affected by rising drug prices.
According to current estimates, diabetes would be the most expensive chronic disease in the United States in 2017, with a total of more than $ 327 billion a year, including $ 15 billion for insulin.²
In November 2018, on the occasion of the second anniversary of the Make Insulin Affordable initiative, the American Diabetes Association (ADA) announced that more than 400,000 diabetes advocates had joined the call affordable insulin for all those who needed it. After reviewing the insulin supply chain, the ADA and its working group on insulin access and affordability published recommendations and policy solutions. to solve the problem. The ADA Make Insulin Affordable website includes information and resources for people who are struggling to pay for insulin, including new patient badistance programs recently launched by insulin manufacturers as well as programs for insulin. 39, private badistance. The site also includes important links to information on the health insurance markets and how to become a diabetes advocate.
This article was originally published on PharmacyTimes.com
References
1. Biniek Fuglesten J, Jonson W. Spending on people with type 1 diabetes and role of a rapid increase in insulin prices. Website of the Institute of Health Care. 2018; Accessed at: https://www.healthcostinstitute.org/research/publications/entry/spending-on-individuals-with-type- 1-diabetes-and-the-role-of-rapidly-increasing-insulin-prices
2. Economic costs of diabetes in the United States in 2017. American Diabetes Association. Diabetic treatments. 2018; dci180007. https://doi.org/10.2337/dci18-0007.
Source link
